{"id":857,"date":"2020-12-01T14:26:33","date_gmt":"2020-12-01T06:26:33","guid":{"rendered":"http:\/\/192.168.6.218\/?p=857"},"modified":"2026-07-21T10:06:02","modified_gmt":"2026-07-21T02:06:02","slug":"tairxs-anti-cancer-drug-cvm-1118-won-the-renewal-of-excelsior-award-in-2020","status":"publish","type":"post","link":"https:\/\/www.trx.com.tw\/en\/tairxs-anti-cancer-drug-cvm-1118-won-the-renewal-of-excelsior-award-in-2020\/","title":{"rendered":"TaiRx\u2019s anti-cancer drug CVM-1118 won the renewal of Excelsior Award in 2020."},"content":{"rendered":"<p class=\"wp-block-paragraph\">Having been awarded the 12<sup>th<\/sup> National Innovation Award in 2015 and the Excelsior Award in 2019, TaiRx\u2019s anti-cancer drug CVM-1118 won the renewal of Excelsior Award in 2020 to praise and recognize CVM-1118\u2019s continuing innovations and advancements in R&amp;D.&nbsp; CVM-1118 (Foslinanib), currently at the stage of Phase II clinical trials, is a potential first-in-class drug for anti-tumor growth and metastasis via strong inhibition on vasculogenic mimicry pathway.<\/p>\n\n\n\n<!--more-->\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/www.trx.com.tw\/wp-content\/uploads\/2020\/12\/1607DSC_6580.jpg\" alt=\"\" class=\"wp-image-2288\"\/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Dr. Yen-Ling Chen, Senior Manager, received the Award on behalf of TaiRx at the 17<sup>th<\/sup> National Innovation Award Ceremony (Photo from Research Center for Biotechnology and Medicine Policy)<\/p>","protected":false},"excerpt":{"rendered":"<p>Having been awarded the 12th National Innovation Award  [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"wp-custom-template-7","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[],"class_list":["post-857","post","type-post","status-publish","format-standard","hentry","category-new-en"],"_links":{"self":[{"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/posts\/857","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/comments?post=857"}],"version-history":[{"count":0,"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/posts\/857\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/media?parent=857"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/categories?post=857"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.trx.com.tw\/en\/wp-json\/wp\/v2\/tags?post=857"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}